The 2023 data on global hospital discharges for hyperplasia of the prostate indicates that Bulgaria leads with 167.2 discharges per 100,000 persons, followed by Belgium at 159.0 and the Czech Republic at 150.1. The data shows varied trends, with Belgium and Austria experiencing slight declines, while South Korea has increased. Sweden and Iceland show significant reductions, with Iceland witnessing a drastic decrease. Looking at these trends over five years, the compounded annual growth rate reveals an overall decline.
Future trends to watch for include potential technological advancements in less invasive treatments which may contribute to continuing declines in hospital discharges and variations across healthcare policies influencing procedure rates. Additionally, aging populations in certain countries could drive differing demands on healthcare services related to prostate health.
Top countries in Hospital Discharges for Hyperplasia of Prostate by Country
| # | 8 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Bulgaria | 167.2 | 2021 | View data | ||
| 2 | 2 Belgium | 159 | 2023 | +2.98% | -0.45% | View data |
| 3 | 3 Czech Republic | 150.1 | 2023 | +5.85% | +0.71% | View data |
| 4 | 4 Austria | 147.1 | 2023 | +2.29% | -1.24% | View data |
| 5 | 5 South Korea | 83.4 | 2023 | +5.04% | +1.43% | View data |
| 6 | 6 Sweden | 53.6 | 2023 | -1.29% | -3.06% | View data |
| 7 | 7 Romania | 46.3 | 2021 | View data | ||
| 8 | 8 Iceland | 7.5 | 2023 | -45.65% | -28.99% | View data |
